1	FDA updates warnings for fluoroquinolone antibiotics	Jul 26, 2016 ... ... a class of antibiotics, called fluoroquinolones, to enhance warnings about their  association with disabling and potentially permanent side effects and to limit their  ... the benefits of fluoroquinolones outweigh the risks and it is appropriate for ...  for irreversible peripheral neuropathy (serious nerve damage).	https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm513183.htm
3	FDA Drug Safety Communication: FDA updates warnings for oral ...	These medicines are associated with disabling and potentially permanent ...  benefits of fluoroquinolones outweigh the risks, and it is appropriate for them to ...  Some signs and symptoms of serious side effects include unusual joint or tendon  pain, ... medicines already have a Boxed Warning for tendinitis, tendon rupture,  and ...	https://www.fda.gov/Drugs/DrugSafety/ucm511530.htm
4	Fluoroquinolone Trouble Untangled | In the Pipeline	May 23, 2018 ... The fluoroquinolone antibiotics are important drugs indeed ... But for many years  now, it's been increasingly clear that this class of drugs can have some ... The  most prominent of these is tendon damage, which often showing up ...... with  disabling and potentially permanent side effects and to limit their use ...	http://blogs.sciencemag.org/pipeline/archives/2018/05/23/fluoroquinolone-trouble-untangled
5	FDA Drug Safety Communication: FDA updates warnings for oral ...	Jul 26, 2016 ... fluoroquinolone antibiotics due to disabling side effects ... medicines are  associated with disabling and potentially permanent side effects of the tendons,  ... side effects include unusual joint or tendon pain, muscle weakness, a “pins  and ... should not prescribe systemic fluoroquinolones to patients who have.	https://www.fda.gov/downloads/Drugs/DrugSafety/UCM513019.pdf
6	EMA Curtails Use of Fluoroquinolone, Quinolone Antibiotics	Nov 16, 2018 ... The new restrictions on the use of fluoroquinolone antibiotics advise against ...  The adverse effects include tendonitis, tendon rupture, arthralgia, pain in the ...  disabling and potentially permanent side effects involving tendons, muscles, ... " The FDA warning was very clear and has already had an effect of ...	https://www.medscape.com/viewarticle/905023
7	Class of antibiotics gets stronger warning due to dangerous side ...	Jul 27, 2016 ... Also, two or more serious side effects can occur together, the FDA said. Because  of this, the FDA recommends reserving these antibiotics for ... Besides Cipro and  Levaquin, other fluoroquinolones include ... The potential for serious nerve  damage (irreversible peripheral neuropathy) was detailed in 2013.	https://www.cbsnews.com/news/class-of-antibiotics-gets-stronger-warning-due-to-dangerous-side-effects-says-fda/
8	Quinolone antibiotic - Wikipedia	A quinolone antibiotic is a member of a large group of broad-spectrum  bactericides that share a ... Spontaneous reports to the U.S. FDA Adverse Effects  Reporting System at the time of ... Quinolones are associated with a small risk of  tendonitis and tendon rupture; a 2013 ... They are best avoided in the athlete  population.	https://en.wikipedia.org/wiki/Quinolone_antibiotic
9	BAXDELA (delafloxacin) Label	prescribing information for BAXDELA. ... potentially irreversible serious adverse  reactions that have ... fluoroquinolones, including BAXDELA, in patients who ....  Effects. 5.2 Tendinitis and Tendon Rupture. 5.3 Peripheral Neuropathy ...  BAXDELA for Injection with other medications [see Dosage and Administration ( 2.4)].	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/208610s000,208611s000lbl.pdf
10	Levofloxacin | FDA Label - Injection (solution), solution, tablet ...	See full prescribing information for complete boxed warning. ... LEVAQUIN® is a  fluoroquinolone antibacterial indicated in adults (18 years of age and .... and  potentially irreversible serious adverse reactions that have occurred together [ see ..... Commonly seen adverse reactions include tendinitis, tendon rupture,  arthralgia ...	https://aidsinfo.nih.gov/drugs/456/levofloxacin/67/professional
